(1S) -4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane Hydrochloride CAS 866783-13-3 Pite > 99.5% (HPLC) Ivabradine Hydrochloride Entèmedyè
Ruifu Chimik Pwovizyon pou Ivabradine Hydrochloride Entèmedyè ak Pite segondè
Ivabradine Hydrochloride CAS 148849-67-6
4,5-Dimethoxy-1-Cyanobenzocyclobutane CAS 35202-54-1
(1S) -4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane Hydrochloride CAS 866783-13-3
7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-yon CAS 73942-87-7
7,8-Dimethoxy-3-(3-yodopropyl)-1,3-dihydro-2H-3-benzazepin-2-yon CAS 148870-57-9
3-(3-Chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2(3H)-yon CAS 85175-59-3
Non Chimik | (1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutan Hydrochloride |
Sinonim | Ivabradine Hydrochloride Entèmedyè;(1S)-4,5-Dimethoxy-1-(Methylaminomethyl)-Benzocyclobutane HCl |
Nimewo CAS | 866783-13-3 |
Nimewo CAT | RF-PI1811 |
Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
Fòmil molekilè | C12H18ClNO2 |
Pwa molekilè | 243,73 |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Poud blan pou blan |
Idantifikasyon | HPLC/UV Konfòme |
Wotasyon espesifik | +14.0° ~ +19.0° (1% CH3OH) |
Pèt sou siye | <0.50% (Seche li nan 105 ℃ nan vakyòm jiskaske yon pwa konstan) |
Enpurte endividyèl | <0.50% |
Izomè optik | <0.50% |
Pite / Metòd analiz | > 99.5% (% nòmalizasyon zòn, pa HPLC) |
Esè | 99.0% ~ 100.5% (sou baz sèk, pa Titration) |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan Ivabradine Hydrochloride (CAS: 148849-67-6) |
Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite
(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane Hydrochloride (CAS: 866783-13-3) se yon entèmedyè ki itilize nan preparasyon Ivabradine Hydrochloride (CAS: 148849-67-6) ki se yon ajan bradycardic selektif ak efè dirèk sou pesmekè a Si kouran nan ne sinoatrial la.Ivabradine diminye vitès depolarize diastolik ak diminye batman kè.Li te apwouve pou tretman anjin kwonik ki estab epi li bay yon altènatif solid pou pasyan ki gen yon kontr oswa entolerans nan b-blockers.Evalyasyon tou sou pye pou tretman potansyèl maladi kè ischemic.